Skip to main content

Genetic CD21 Deficiency

  • Chapter
  • First Online:
Humoral Primary Immunodeficiencies

Part of the book series: Rare Diseases of the Immune System ((RDIS))

  • 763 Accesses

Abstract

CD21 (complement receptor 2, CR2) deficiency has been first described in 2012 by Thiel et al. in a single patient. To date, three further patients have been reported. CD21 deficiency is caused by compound heterozygous or homozygous mutations in the CD21 gene. The CD21-deficient patients may have a relatively mild clinical phenotype with recurrent bacterial infections and autoimmune-mediated myalgia or a more severe phenotype with recurrent upper and lower respiratory tract infections first presenting in early childhood. CD21 deficiency should be ruled out in patients with clinical signs of humoral immunodeficiency, hypogammaglobulinemia, and a decrease in class-switched memory B cells. The absence of CD21 expression on peripheral B cells can easily be detected by immunophenotyping.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Thiel J, Kimmig L, Salzer U, Grudzien M, Lebrecht D, Hagena T, Draeger R, Voelxen N, Bergbreiter A, Jennings S, Gutenberger S, Aichem A, Illges H, Hannan JP, Kienzler AK, Rizzi M, Eibel H, Peter HH, Warnatz K, Grimbacher B, Rump JA, Schlesier M. Genetic CD21 deficiency is associated with hypogammaglobulinemia. J Allergy Clin Immunol. 2012;129(3):801–810.e6. https://doi.org/10.1016/j.jaci.2011.09.027.

    Article  CAS  PubMed  Google Scholar 

  2. Wentink MW, Lambeck AJ, van Zelm MC, Simons E, van Dongen JJ, IJspeert H, Schölvinck EH, van der Burg M. CD21 and CD19 deficiency: two defects in the same complex leading to different disease modalities. Clin Immunol. 2015;161(2):120–7. https://doi.org/10.1016/j.clim.2015.08.010.

    Article  CAS  PubMed  Google Scholar 

  3. Rosain J, Miot C, Lambert N, Rousselet MC, Pellier I, Picard C. CD21 deficiency in 2 siblings with recurrent respiratory infections and hypogammaglobulinemia. J Allergy Clin Immunol Pract. 2017;5(6):1765–1767.e3. https://doi.org/10.1016/j.jaip.2017.04.011.

    Article  PubMed  Google Scholar 

  4. Carter RH, Fearon DT. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science. 1992;256(5053):105–7.

    Article  CAS  Google Scholar 

  5. Szakonyi G, Guthridge JM, Li D, Young K, Holers VM, Chen XS. Structure of complement receptor 2 in complex with its C3d ligand. Science. 2001 Jun 1;292(5522):1725–8.

    Article  CAS  Google Scholar 

  6. Aegerter-Shaw M, Cole JL, Klickstein LB, Wong WW, Fearon DT, Lalley PA, Weis JH. Expansion of the complement receptor gene family. Identification in the mouse of two new genes related to the CR1 and CR2 gene family. J Immunol. 1987;138(10):3488–94.

    CAS  PubMed  Google Scholar 

  7. Iida K, Nadler L, Nussenzweig V. Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody. J Exp Med. 1983;158(4):1021–33.

    Article  CAS  Google Scholar 

  8. Erdei A, Isaák A, Török K, Sándor N, Kremlitzka M, Prechl J, Bajtay Z. Expression and role of CR1 and CR2 on B and T lymphocytes under physiological and autoimmune conditions. Mol Immunol. 2009;46(14):2767–73. https://doi.org/10.1016/j.molimm.2009.05.181.

    Article  CAS  PubMed  Google Scholar 

  9. Molina H, Holers VM, Li B, Fung Y, Mariathasan S, Goellner J, Strauss-Schoenberger J, Karr RW, Chaplin DD. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc Natl Acad Sci U S A. 1996;93(8):3357–61.

    Article  CAS  Google Scholar 

  10. van Zelm MC, Reisli I, van der Burg M, Castaño D, van Noesel CJ, van Tol MJ, Woellner C, Grimbacher B, Patiño PJ, van Dongen JJ, Franco JL. An antibody-deficiency syndrome due to mutations in the CD19 gene. N Engl J Med. 2006;354(18):1901–12.

    Article  Google Scholar 

  11. van Zelm MC, Smet J, Adams B, Mascart F, Schandené L, Janssen F, Ferster A, Kuo CC, Levy S, van Dongen JJ, van der Burg M. CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency. J Clin Invest. 2010;120(4):1265–74. https://doi.org/10.1172/JCI39748.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jens Thiel .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Thiel, J. (2019). Genetic CD21 Deficiency. In: D'Elios, M., Rizzi, M. (eds) Humoral Primary Immunodeficiencies. Rare Diseases of the Immune System. Springer, Cham. https://doi.org/10.1007/978-3-319-91785-6_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-91785-6_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-91784-9

  • Online ISBN: 978-3-319-91785-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics